Geert Claeys 1School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia; 2School of Medical Laboratory Sciences, Institute of Health, Jimma University, Jimma, Ethiopia; 3Department of Diagnostic Sciences, Ghent University, Ghent, Belgium; 4Laboratories of Medical Microbiology, Ghent University Hospital, Ghent, Belgium

Cytomegalovirus( CMV) infection during gestation is a major cause of natural infection worldwide. natural CMV( cCMV) infection can affect in significant morbidity, mortality, or long- term sequelae, including sensorineural hail loss. Although the increase of mindfulness and transnational guidelines on the operation of cCMV is observed across the advanced country, data in Africa on rates of natural and motherly CMV infection are rather scarce and haphazard. Published data are collected in this review indicating a high pooled frequence of CMV IgG among pregnant women in Africa(87.4, range of 72- 100) as well as pooled reported cCMV frequence in the invigorated(3.3, range of1.3-6.3).

CMV infection during gestation is a major cause of natural infection in developing countries( 1). The high motherly seroprevalence of CMV IgG doesn't count the trouble of cCMV infection and clinically apparent complaint in the invigorated as cCMV is also common among pregnant women withpre-existing CMV IgG antibodies due to threat of reactivation or reinfection with a different viral strain( 2). Yet a pregnant woman with primary CMV infection is more likely to transmit infection compared to the mama with reactivation or intermittent( secondary) infection( 3).

cCMV infection can affect in significant morbidity, mortality, or long- term sequelae, including sensorineural hail loss in an affected infant. Despite being a leading cause of natural infections worldwide, presently, there are no global programs that offer motherly or neonatal webbing to identify infected maters and babies, no vaccines as well as no efficient and safe curatives in pregnant or babe are available( 4). Depending on the characteristics of a specific motherly population similar as age, profitable status, andco-existing sexually transmitted infections including mortal Immunodeficiency Contagion( HIV), the frequence of cCMV varies across the world. Low frequence of cCMV infections is reported in developed countries, while the

loftiest frequence is recorded in Africa, Southern Asia, and South America( 5). Studies have also indicated the liability of being CMV seropositive before generality correlates negatively with socioeconomic status and is 92, 47, and 34 in expectant maters with low, middle, and high socioeconomic status, independently( 6).

This review summarizes natural CMV and seroprevalence of CMV infection among African pregnant women. A PubMed and Google scholar hunt of the English- language literature was done using the following hunt term( frequence of CMV among pregnant women and natural CMV infection in Africa( title)) AND( CMV among pregnant women * OR motherly CMV * OR motherly and natural CMV OR Cytomegalovirus * OR “ In Africa ”( Mesh) OR Africa OR Current vacuity of public and transnational guidelines on cCMV in Africa OR presently available and habituated individual tools in Africa for cCMV( title)). The references of included studies were also searched for seeker papers. We included studies that applied validated CMV tests to cases. All studies on a specific population( pregnant women and babe) were included. All available papers published up to June 2020 was included and exported to Endnote interpretation7.1.

Studies from northern Africa have indicated the large burden of motherly CMV in the region. As to the study from Egypt, a 100 CMV IgG positivity among tested 546 pregnant women and40/546(7.3) positive or equivocal IgM antibodies were reported( 7). also study in Tunisian also has reported a high(96.3) CMV seroprevalence among pregnant women( 8). motherly CMV seroprevalence in East Africa varied from 72-97.5. One Kenyan study( 9) set up a fairly lower frequence,77.3, of IgG and8.1 of IgM while the other Kenyan study reported a advanced frequence93.1 of CMV IgG among 1066 pregnant women( 10). Likewise in Tanzania,73.9 of pregnant women had IgG antibodies while IgM antibodies were present only in0.4( 11). also, the other Tanzanian study which was conducted on 368 pregnant women attending Sexually Transmitted conditions( STDs) and prenatal conventions had reported a frequence of 94 IgG and8.5 IgM. According to the study CMV IgM was detected in advanced figures of cases with STDs than in those without STDs( 12).

Again in a analogous manner out of 231 Sudanese pregnant women,72.2 and2.5 were seropositive for CMV IgG and2.5 CMV- IgM, independently( 13), whereas, in another Sudanese study, out of the 200 pregnant women tested 195(97.5) IgG and 12(6.0) CMV IgM was reported( 14). A study conducted atSt. Paul’s Millennium Medical College Hospital, Addis Ababa, Ethiopia, reported a95.5 CMV IgG and5.5 CMV IgM positivity among pregnant women( 15). On the same point, among 200 pregnant women, the seroprevalence of88.5( IgG) and rather a high chance of15.5 for IgM were reported( 16).

In West Africa, seroprevalence is reported in the range from 60- 100. A study at Kano State of Nigerian bared91.1 CMV IgG seropositivityamong 180 pregnant women( 17). The other Nigerian study set up11.1 CMV IgM positive while93.9 were positive for CMV IgG among HIV seropositive pregnant women( 18). A study in Nigeria at Lagos State University Teaching Hospital has reported97.2 of pregnant women being positive for CMV IgG( 19).

The other West African countries also reported a high frequence of CMV antibodies among pregnant women. A study on 169 Gambian pregnant women set up a 100 CMV IgG positivity( 20). A analogous finding was also reported in Ghana, a 100 frequence of CMV IgG among tested 172 pregnant women( 21). In Benin, among 211 pregnant women97.2 were positive for CMV IgG and 6 positive for CMV IgM( 22). On the other hand, according to the molecular assay of 200 samples from pregnant women in Burkina Faso, 13(6.5) were positive for CMV( 23).

Reports from Southern Africa have shown nearly 100 seroprevalence of motherly CMV. In Namibia 100 frequence of CMV IgG and a3.2 CMV IgM was proved( 24). In Zimbabwe,99.6 IgG and4.6 IgM positivity were reported. The study also proved that CMV seroprevalence wasn't associated with the HIV status of the women, maybe due to the ubiquitous exposure of the population to CMV( 25). A study in Mozambique also reported 100 IgG frequence among 118 pregnant women( 26). In South Africa, among,250 asymptomatic pregnant women who were delved for active CMV infection, 132(5.9) were positive for active CMV infection. Among the 132 cases with active CMV, only 5 primary infections(3.8) were diagnosed; the vast maturity 127( 96) had reactivation or reinfection performing in the transplacental transmission rate of6.4( 27). The cited studies on CMV seroprevalence in pregnant women in Africa are presented in To epitomize the pooled reported frequence of CMV IgG among pregnant women in Africa was87.4(4864/5563) with a range of 72- 100.

Compared to the world examinations cCMV in babe are scarce in Africa. When we tabulate the published data on natural infections in Africa( Table 2), the number of babes tested for cCMV infection varied from 115 to 2685, and all clinical samples were collected within 2 weeks of birth. In 9 studies PCR ways were used for the discovery of CMV, urine culture in 2, and antibody discovery with ELISA in a single study. utmost of the studies have used urine or slaver samples while only one study has used umbilical cord and nasopharyngeal aspirates.

In Egypt a study by Salwa etal. linked cCMV in1.3 of 178 babe using PCR fashion on slaver sample( 28) whereas the other Egyptian study set up a advanced frequence of cCMV infection,5.7 using urine culture( 29). In a study in Kenya using slaver tar and PCR on Dried Blood Spot( DBS), out of 1078 invigorated 39(3.6) were positive for cCMV infection. According to this study motherly HIV infection may increase the threat of cCMV infection, but the part of motherly malaria on the intrauterine transmission of CMV remains unclear( 10). A study from Ethiopia conducted using a serological test set up a1.3 frequence of cCMV in babe( 15). But in this study, a CMV IgM grounded assay known for low perceptivity and particularity was used( 1). In a case series report of four children with acute CMV infections diagnosed clinically and serologically the author emphasizes the need for advanced individual tools for natural and acquired nonage CMV infections in Ethiopia( 30).

5.4 among babe. In a Study from Lagos, Nigeria, CMV was reported in 10 of 263 births(3.8) grounded on an RT- PCR assay on dried slaver samples( 31). In Ivory Coast, 28 of 2032(1.4) invigorated babies had cCMV infection grounded on examinations on urine culture( 32). In a cohort study of Gambian term babies, cCMV infection was detected in 40(5.4) of 741 tested babies using PCR ways from urine samples at birth( 33). In another Gambian study, cCMV infection was detected in 11(3.9) of 281 babies on urine samples attained within the first 2 weeks of birth using the PCR system( 20).

In Southern Africa, a advanced rate of cCMV compared to the rest African region was reported. In a Mozambican quarter sanitarium, 3 babe out of 115(2.6) were positive for cCMV using a PCR assay from an umbilical cord sample. This study also used nasopharyngeal aspirate samples from part of these babes. Consequently, in 6 of 96(6.3) cCMV were detected. The authors indicate the significant incident of perpendicular transmission of CMV in southern Mozambique( 26). In Zambia from 395 bambino samples tested on urine and slaver by PCR,3.8(15/395) were diagnosed with cCMV( 34). The study reported a advanced frequence of cCMV among babes born to HIV- infected maters ;11.4, compared to only2.1 among babes born to uninfected maters .

In agreement, in Johannesburg, South Africa, significantly advanced cCMV frequence was reported in HIV- exposed babes,(5.2, 95 CI3.8-6.9) than HIV unexposed babes(1.4, 95 CI0.9-2.0). The threat of in utero HIV infection was20-fold lesser( odds rate20.1, 95 CI6.09-66.46) among cCMV infected babes( 35). In discrepancy, in another Southern Africa study in one of the pastoral central hospitals in South Africa, a5.96 frequence of cCMV was reported using a PCR assay on a slaver tar. But frequence was equal in HIV exposed and HIV unexposed babes{ frequence rate( PR) = 1.00; 95 CI0.94-1.06; p = 0.869}, and hence there was no association between motherly HIV status and cCMV. The study also assessed other factors associated with cCMV. Consequently, babe with a birth weight of< 2400 g were either 5 or 7 more likely to have cCMV than those with advanced birth weight of between 2400 and 3500 g( PR = 1.05; 95 CI0.97-1.14; p = 0.249)

which utmost current transnational guidelines don't recommend. In African countries, the lack of routine testing for CMV in pregnant women isn't only the result of the absence of astronomically available recommendations but is also substantially due to theun-affordability of test accoutrements

The opinion of CMV infection can be made by detecting contagion-specific IgG and IgM antibodies in the serum of a pregnant woman. The presence of IgG antibodies indicates a once infection from 2 weeks to several times duration while IgM assays have been assessed in pregnant women as an index of acute or recent infection. still, IgM can be produced in pregnant women with non-primary CMV infections( 37). As a result serologic assessment of CMV IgG along with CMV IgM and IgG avidity of a pregnant woman can identify gravidity at threat of transmitting CMV to the fetus. The CMV IgG avidity assay is considered a primary tool to date the timing of an infection. Chancing CMV IgM antibodies with low CMV IgG avidity indicates primary infection within the antedating 3- 4 months with an increased threat of intrauterine transmission to the fetus. Whereas with high avidity, the threat of transmission is lower. thus, if avidity testing is available, the presence of IgM antibody and low- avidity IgG antibody provides strong substantiation of recent primary infection( 38).

Viral culture of the urine and slaver attained within the first two weeks of life continue to be the gold standard for opinion of constitutionally infected babies. But slaver PCR assays are presently being assessed as a useful system for cCMV infection as constitutionally infected babe persistently exfoliate veritably high situations of CMV in the slaver and urine( 4). virtually babe need to be diagnosed if there's clinical dubitation of cCMV infection or the mama having a former history of CMV infection. still, in Africa opinion of cCMV for the clinically suspected invigorated is virtuallynon-existing due to the lack of mindfulness, laboratory capacities, and guidelines. Yet a veritably little number of reports substantiation the significance of cCMV in Africa( 1).

carrying the slaver sample at least 1 hour after suckling to avoid implicit impurity with CMV from bone milk is essential to reduce the threat of impurity from mama bone milk. Studies formerly revealed that PCR assay of slaver showed high perceptivity and particularity and PCR appears to identify further constitutionally infected babe that would be missed by rapid-fire culture( 4). still, the cost of a comprehensive opinion of CMV infection is unaffordable in Africa.

1. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital Cytomegalovirus. Clin Microbiol Rev. 2013;26:86-102.

2. Britt WJ. Maternal immunity and the natural history of congenital human Cytomegalovirus infection. Viruses. 2018;10:405.

3. Bonalumi S, Trapanese A, Santamaria A, D’Emidio L, Mobili L. Cytomegalovirus infection in pregnancy: Review of the literature. J Prenat Med. 2011;5:1-8.

4. Lazzarotto T, Blázquez-Gamero D, Delforge ML, Foulon I, Luck S, Modrow S, et al. Congenital Cytomegalovirus infection: A narrative review of the issues in screening and management from a panel of European experts. Front Pediatr. 2020;8:13.

5. Barbosa NG, Yamamoto AY, Duarte G, Aragon DC, Fowler KB, Boppana S, et al. Cytomegalovirus shedding in seropositive pregnant women from a high-seroprevalence population: The Brazilian cytomegalovirus hearing and maternal secondary infection study. Clin Infect Dis. 2018;67:743-750.

6. Enders G, Daiminger A, Bäder U, Exler S, Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary Cytomegalovirus infection in relation to gestational age. J Clin Virol. 2011;52:244-246.

7. Kamel N, Metwally L, Gomaa N, Ahmed WS, Lotfi M, Younis S. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by Cytomegalovirus IgG avidity testing. Med Princ Pract. 2014;23:29-33.

8. Hannachi N, Marzouk M, Harrabi I, Ferjani A, Ksouri Z, Ghannem H, et al. Seroprevalence of Rubella virus, Varicella Zoster virus, Cytomegalovirus and Parvovirus B19 among pregnant women in the Sousse region, Tunisia. Pathol Exot. 2011;104:62-67.

9. Maingi Z, Nyamache AK. Seroprevalence of Cytomegalovirus (CMV) among pregnant women in Thika, Kenya. BMC Res Notes. 2014;7:794.

10. Otieno NA, Nyawanda BO, Otiato F, Oneko M, Amin MM, Otieno M, et al. The impact of maternal HIV and malaria infection on the prevalence of congenital Cytomegalovirus infection in Western Kenya. J Clin Virol. 2019;120:33-37.

11. Chibwe E, Mirambo MM, Kihunrwa A, Mshana SE. Magnitude of the Cytomegalovirus infection among pregnant women attending antenatal clinics in the city of Mwanza, Tanzania. BMC Res Notes. 2017;10:489.

12. Ray K, Mahajan M. Seroprevalence of Cytomegalovirus antibodies in patients attending STD and antenatal clinics. J Commun Dis. 1997;29:85-90.

13. Hamdan HZ, Abdelbagi IE, Nasser NM, Adam I. Seroprevalence of Cytomegalovirus and rubella among pregnant women in western Sudan. Virol J. 2011;8:217.

14. Khairi SI, Intisar KS, Enan KH, Ishag MY, Baraa AM, Ali YH. Seroprevalence of Cytomegalovirus infection among pregnant women at Omdurman Maternity Hospital, Sudan. J Med Lab Diagn. 2013;4:45-49.15. Mamuye Y, Nigatu B, Bekele D, Getahun M. Maternal and congenital Cytomegalovirus infection and zero rubella IgM prevalence in newborns in St. Paul’s Hospital Millennium Medical College. BMC Res Notes. 2016;9:476.

15. Mamuye Y, Nigatu B, Bekele D, Getahun M. Maternal and congenital Cytomegalovirus infection and zero rubella IgM prevalence in newborns in St. Paul’s Hospital Millennium Medical College. BMC Res Notes. 2016;9:476.

16. Yeshwondm M, Balkachew N, Delayehu B, Mekonen G. Seroepidemiology study of Cytomegalovirus and rubella among pregnant women at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. Ethiop J Health Sciences. 2016;26:427-438.

17. Hamid KM, Onoja AB, Tofa UA, Garba KN. Seroprevalence of Cytomegalovirus among pregnant women attending Murtala Mohammed Specialist Hospital Kano, Nigeria. Afr Health Sci.

18. 2014;14:125-130.

19. Fowotade A, Okonko IO, Agbede OO, Suleiman ST. High seropositivity of IgG and IgM antibodies against Cytomegalovirus (CMV) among HIV- 1 seropositive patients in Ilorin, Nigeria. Afr Health Sci. 2015;15:1-9.

20. Akinbami AA, Rabiu KA, Adewunmi AA, Wright KO, Dosunmu AO, Adeyemo TA, et al. Seroprevalence of c Cytomegalovirus antibodies amongst normal pregnant women in Nigeria. Int J Womens Health. 2011;3:423.

21. Kaye S, Miles D, Antoine P, Burny W, Ojuola B, Kaye P, et al. Virological and immunological correlates of mother-to-child transmission of Cytomegalovirus in The Gambia. J Infect Dis 2008. 2008;197:1307-1314.

22. Völker F, Cooper P, Bader O, Uy A, Zimmermann O, Lugert R, et al. Prevalence of pregnancy-relevant infections in a rural setting of Ghana. BMC pregnancy and childbirth. 2017;17:172.

23. Rodier MH, Berthonneau J, Bourgoin A, Giraudeau G, Agius G, Burucoa C, et al. Seroprevalences of Toxoplasma, malaria, rubella, Cytomegalovirus, HIV and treponemal infections among pregnant women in Cotonou, Republic of Benin. Acta Trop. 1995;59:271-277.

24. Ouedraogo AR, Kabre M, Bisseye C, Zohoncon TM, Asshi M, Soubeiga ST, et al. Molecular tests in diagnosis of Cytomegalovirus (CMV), Human Herpes Virus 6 (HHV-6) and Epstein-Barr Virus (EBV) using real-time PCR in HIV positive and HIV-negative pregnant women in Ouagadougou, Burkina Faso. Pan Afr Med J. 2016;24:223.

25. Van der Colf BE, Van Zyl GU, Mackenzie SB. Seroprevalence of Cytomegalovirus among pregnant women in Windhoek, Namibia, 2016. S Afr J Obstet Gynaecol. 2019;25:52.

26. Mhandire D, Duri K, Kaba M, Mhandire K, Musarurwa C, Chimusa E, et al. Seroprevalence of Cytomegalovirus infection among HIV- infected and HIV-uninfected pregnant women attending antenatal clinic in Harare, Zimbabwe. Viral Immunol. 2019;32:289-295.

27. Madrid L, Varo R, Maculuve S, Nhampossa T, Munoz-Almagro C, Calderon EJ, et al. Congenital Cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: A cross- sectional survey. PloS one. 2018;13:e0194186.

28. Schoub BD, Johnson S, McAnerney JM, Blackburn NK, Guidozzi F, Ballot D, et al. Is antenatal screening for rubella and Cytomegalovirus justified? S Afr Med J. 1993;83:108-110.

29. Salwa ES, Abdel Hamid KSEA-W, Saleh LH, Davis GE,Hastie I, James C. Booth: comparative epidemiology of infection with human Cytomegalovirus in Cairo and South London. Int J Virol. 2011;7:116-122.

30. Morgan MA, Khalifa NA, Sherif A, Rasslan LR. Prevalence of Cytomegalovirus (CMV) Infection Among Neonatal Intensive Care Unit (NICU) and healthcare workers. Egypt J Immunol. 2003;10:1-8.

31. Alemayehu T, Abebe W, Hailu D. Childhood Cytomegalovirus infection: Case series and literature review. Virol Mycol. 2017;6:2161-0517.

32. Olusanya BO, Slusher TM, Boppana SB. Prevalence of congenital cytomegalovirus infection in Nigeria: A pilot study. Pediatr. Infect Dis J. 2015;34:322-324.

33. Schopfer K, Lauber E, Krech U. Congenital Cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child. 1978;53:536-539.

34. Van der Sande MA, Kaye S, Miles DJ, Waight P, Jeffries DJ, Ojuola OO, et al. Risk factors for and clinical outcome of congenital Cytomegalovirus infection in a peri-urban West-African birth cohort. PloS One. 2007;2:e492.

35. N M, Chilukutu L TJ, Kabwe M, Musonda K, Kapasa M, Chabala C, et al. High rates of congenital Cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in Sub-Saharan Africa. Clin Infect Dis. 2014;58:728-735.

36. Pathirana J, Groome M, Dorfman J, Kwatra G, Boppana S, Cutland C, et al. Prevalence of congenital Cytomegalovirus infection and associated risk of in utero Human Immunodeficiency Virus (HIV) acquisition in a high-hiv prevalence setting, South Africa. Clin Infect Dis 2019;69:1789-1796.

37. Tshabalala D, Newman H, Businge C, Mabunda SA, Kemp W, Beja

38. P. Prevalence and determinants of congenital Cytomegalovirus infection at a rural South African central hospital in the Eastern Cape. S Afr J Infect Dis. 2018;33:89-92.

39. Wissel N, Hanschmann KM, Scheiblauer H, Report of the WHO

40. collaborative study to establish the first international standard for detection of IgG antibodies to Cytomegalovirus (anti-CMV IgG). WHO;2017.

41. Pass RF, Arav-Boger R. Maternal and fetal c Cytomegalovirus infection: diagnosis, management, and prevention. F1000Res. 2018;7:255-255.

42. Parmigiani SV, Barini R, Costa SC, Amaral E, Silva JC, Pinto, et al. Accuracy of the serological ELISA test compared with the polymerase chain reaction for the diagnosis of Cytomegalovirus infection in pregnancy. Sao Paulo Med J. 2003;121:97-101.

Zeleke Mekonnen2. Natural Cytomegalovirus Infections. Insights Journal of Obstetrics And Gynecology 2022.